Farms.com Home   News

Body Cameras Enable Remote Animal Welfare Assessments Amid COVID

The use of body cameras is proving valuable in conducing animal welfare assessments amid the current restrictions designed to prevent the spread of COVIDD-19. Researchers with Western College of Veterinary Medicine have evaluated the use of body cameras, similar to those used by police departments, as an option for barn personnel to support remote animal welfare assessments.
 
Dr. Giuliana Miguel Pacheco, a Post Doctoral Research Fellow in the Department of Large Animal Clinical Sciences at the Western College of Veterinary Medicine, explains animal welfare assessments can be used by producers to monitor the wellbeing of their pigs and by assurance programs such as the Canadian Quality Assurance program.
 
Clip-Dr. Giuliana Miguel Pacheco-Western College of Veterinary Medicine:
 
Because of animal welfare science, we know that animals require minimum living conditions to have a live worth living. So, welfare assessments are carried out to assess that animal care standards are providing animals with good welfare.
 
Running welfare assessments and using the information to improve living conditions could improve consumer trust in farms especially with the public. Body cameras become part of the picture because they facilitate the monitoring of animals at any point in time or monitoring various farms at the same time.
 
Body cameras could help producers to manage their animals more effectively or to help production managers streamline assessments of several barns at the same which in turn can support improvement of animal care and management within companies, of their own animals. On top of these benefits for animals and producers are the associated benefits of reducing costs of travel for those in charge of assessments and biosecurity risks for the farms involved.
Source : Farmscape

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.